Get 20% lifetime commission for referring investors to digrin.com
here.
Oryzon Genomics S.A. ( ORYZF) - Key Metrics
ORYZF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0 | $0 | $0 |
| 2026Q1 | $0 | -$0.02 | $0 | $0 |
| 2025Q4 | $0 | -$0.02 | $0 | $0 |
| 2025Q3 | $0 | $0 | $0 | $0 |
| 2025Q2 | $0.05 | $0 | $0 | $0 |
ORYZF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -443.73 |
| 2026Q1 | 0% | -46.31 |
| 2025Q4 | 0% | -41.09 |
| 2025Q3 | 0% | 159.99 |
| 2025Q2 | 0% | -1707.61 |
ORYZF
Price: $3.10
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 253.9 million